NasdaqGM - Delayed Quote USD

Castle Biosciences, Inc. (CSTL)

20.34 +0.83 (+4.25%)
At close: April 26 at 4:00 PM EDT
20.34 0.00 (0.00%)
After hours: April 26 at 4:20 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for CSTL

Recent News: CSTL

View More
We're Not Worried About Castle Biosciences' (NASDAQ:CSTL) Cash Burn

We're Not Worried About Castle Biosciences' (NASDAQ:CSTL) Cash Burn
Simply Wall St. 10 days ago
Castle Biosciences to Release First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 2, 2024

Castle Biosciences to Release First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 2, 2024
Business Wire 16 days ago
Castle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational Collaborations

Castle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational Collaborations
Business Wire 17 days ago
Castle Biosciences’ Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive Year

Castle Biosciences’ Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive Year
Business Wire 17 days ago
What Makes Castle Bioscience (CSTL) a Prospective Investment?

What Makes Castle Bioscience (CSTL) a Prospective Investment?
Insider Monkey 22 days ago
Presentations at EADO Highlight Potential Impact of Castle Biosciences’ DecisionDx®-Melanoma and DecisionDx®-SCC Tests on the Management of Patients with Skin Cancer

Presentations at EADO Highlight Potential Impact of Castle Biosciences’ DecisionDx®-Melanoma and DecisionDx®-SCC Tests on the Management of Patients with Skin Cancer
Business Wire 23 days ago
Castle Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

Castle Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
Business Wire 25 days ago

Castle Biosciences Announces Updates to its Board of Directors
Business Wire last month
Castle Biosciences Earns a Top Workplaces USA Award for the Third Consecutive Year

Castle Biosciences Earns a Top Workplaces USA Award for the Third Consecutive Year
Business Wire last month
Long-term Outcomes Data Shared at SSO 2024 Show That Patients with a Low-Risk DecisionDx®-Melanoma Test Result Were Recurrence Free at Three Years, Including Those Who Utilized the Test to Help Guide the Decision to Avoid an SLNB

Long-term Outcomes Data Shared at SSO 2024 Show That Patients with a Low-Risk DecisionDx®-Melanoma Test Result Were Recurrence Free at Three Years, Including Those Who Utilized the Test to Help Guide the Decision to Avoid an SLNB
Business Wire last month
Does Castle Bioscience (CSTL) Have Robust Growth Prospects?

Does Castle Bioscience (CSTL) Have Robust Growth Prospects?
Insider Monkey last month
Leading Squamous Cell Carcinoma Practitioners Publish Consensus Guidelines Integrating DecisionDx®-SCC into a Clinical Workflow to Improve Decision-Making Regarding the Use of Adjuvant Radiation Therapy

Leading Squamous Cell Carcinoma Practitioners Publish Consensus Guidelines Integrating DecisionDx®-SCC into a Clinical Workflow to Improve Decision-Making Regarding the Use of Adjuvant Radiation Therapy
Business Wire last month
View More

Related Tickers

BDSX Biodesix, Inc.
1.2350
-1.98%
 
DMTK DermTech, Inc.
0.6031
+3.02%
 
ECX.F EPIGENOMICS AG NA O.N.
1.5150
0.00%
 
BCART.BR Biocartis Group NV
0.2900
0.00%
 
MYGN Myriad Genetics, Inc.
18.18
+1.11%
 
CNTG Centogene N.V.
0.4889
+1.88%
 
STIM Neuronetics, Inc.
3.4900
-0.85%
 
NEOG Neogen Corporation
12.14
+1.51%
 
VNRX VolitionRx Limited
0.9137
+2.65%
 
NDRA ENDRA Life Sciences Inc.
0.2525
+4.21%